Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease. (3rd May 2020)

• Record Type: Journal Article
• Authors: Rengarajan, Sunaina; Vivio, Emily E.; Parkes, Miles; Peterson, Daniel A.; Roberson, Elisha D.O.; Newberry, Rodney D.; Ciorba, Matthew A.; Hsieh, Chyi-Song
• Is Part Of: Gut microbes. Volume 11:Isuse 3(2020)
• Page Start: 405
• Page End: 420
• Publication Date: 2020-05-03
• Subjects: Inflammatory bowel disease -- immunoglobulin A -- IgA -- IgG -- gut bacteria -- microbiota; Gastrointestinal system -- Microbiology -- Periodicals; Microbiology -- Periodicals; Intestine, Small -- Periodicals; 616.3
• DOI: 10.1080/19490976.2019.1626683
• Languages: English
• ISSNs: 1949-0984

Abstract

ABSTRACT: Aberrant immune responses against gut microbiota are thought to be key drivers of inflammatory bowel disease (IBD) pathogenesis. However, the extent and targets of immunoglobulin (Ig) A versus IgG responses to gut bacteria in IBD and its association with IBD severity is not well understood. Here, we address this by analyzing fecal samples from Crohn's disease (CD), ulcerative colitis (UC), and Non-IBD patients by flow cytometry for the frequency of bacteria that were endogenously bound with IgA and/or IgG. Assessment of IBD patients from two geographically distinct cohorts revealed increased percentages of IgA- and IgG-bound fecal bacteria compared to non-IBD controls. Notably, the two major subsets of IBD showed distinct patterns of Ig-bound bacteria, with CD activity associated with increases in both IgA and IgG-bound bacteria, whereas UC activity correlated only with increases in IgG-bound bacteria. Analysis of the flow sorted Ig-bound bacterial repertoire by 16S rDNA sequencing revealed taxa that were Ig-bound specifically in IBD. Notably, this included bacteria that are also thought to reside in the oral pharynx, including Gemella, Peptostreptococcus, and Streptococcus species. These data show that the pattern of IgA and IgG binding to fecal bacteria is distinct in UC and CD. In addition, the frequency of Ig-bound fecal bacteria may have potential as a non-invasive biomarker for disease activity. Finally, our results support the hypothesis that immune responses to oral pharyngeal bacteria may play an important role in the pathogenesis of IBD.